Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Cell & Gene Therapy International Europe

Countdown to the Event

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
3-5 November 2026
Hotel Palace BerlinBerlin, Germany
Book Now
Menu
Book
Key Sessions
Simone Zanetti
Case Study: Potency Strategy and Regulatory Interactions for Hemgenix
CSL Behring
keyboard_arrow_right

Thursday 5th November – Day 2 Main Conference - GMT (Greenwich Mean Time, GMTZ)

keyboard_arrow_leftSearch & Filter
search
Thursday 5th November – Day 2 Main Conference - GMT (Greenwich Mean Time, GMTZ)
search
Showing 1 of 1 Streams
08:30 - 09:00
Registration & Morning Coffee
Showing 4 of 4 Streams
09:00 - 09:10
Chairperson’s Opening Remarks: Cell Therapy Manufacturing & Analytics
  • Catherine Simpson - Conference Director - Cell and Gene Therapy Portfolio, Informa Connect LifeSciences
09:10 - 09:40
Bridging Viral and Lipid Nanoparticle Worlds: Surface Engineering Lentiviral Vector-Based Nanoparticles for Targeted In Situ CAR-T Cell Therapy
  • Céline Jaudouin - Senior Formulation Scientist, Alaya.bio
09:40 - 10:40
Panel Discussion: Scale-Up Strategies: Navigating the Road Ahead for In Vivo CAR-T
  • Lorenz Mayr - Managing Director, BioMedTech Consulting GmbH
  • Matthias Bozza - Director, Head of Strategy and R&D, CPTx
  • Ulf Grawunder - Co-founder & CEO, T-CURX
09:00 - 09:10
Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics
  • Christine Le Bec - Deputy CTO, Head of Analytical Development & QC, Sensorion
09:10 - 09:40
Manufacturing Challenges and Control Strategies For Dual AAV Vectors - Characterisation and Analytical Methods
  • Christine Le Bec - Deputy CTO, Head of Analytical Development & QC, Sensorion
09:40 - 10:10
Case Study: Potency Strategy and Regulatory Interactions for Hemgenix
  • Simone Zanetti - Global Head of QC Analytical Technologies, Gene Therapy, CSL Behring
10:10 - 10:40
Mastering hcDNA: A Harmonized Approach for AAV Gene Therapies
  • Nic Preyat - Associate Director, Process Sciences, CMC Development - Gene Therapy, UCB
09:05 - 09:10
Chairperson's Opening Remarks: Exosomes Europe 2026
09:10 - 09:40
Smart EV Biomanufacturing: Balancing Yield, Purity & Scale from Lab to Clinic
  • Jan Schrooten - CEO, Antleron
09:40 - 10:10
Academic Spotlight Session
10:10 - 10:40
Scientific Track Presentation: Downstream Purity & Quality Control
09:10 - 09:40
ROOM EUROPA 6: Bridging Viral and Lipid Nanoparticle Worlds: Surface Engineering Lentiviral Vector-Based Nanoparticles for Targeted In Situ CAR-T Cell Therapy
  • Céline Jaudouin - Senior Formulation Scientist, Alaya.bio
09:40 - 10:40
ROOM EUROPA 6: Panel Discussion: Scale-Up Strategies: Navigating the Road Ahead for In Vivo CAR-T
  • Lorenz Mayr - Managing Director, BioMedTech Consulting GmbH
  • Matthias Bozza - Director, Head of Strategy and R&D, CPTx
  • Ulf Grawunder - Co-founder & CEO, T-CURX
Showing 2 of 2 Streams
10:40 - 11:20
Morning Coffee and Networking Break in Exhibition Hall
10:40 - 11:20
Poster Viewing - Meet the Poster Presenters

Explore groundbreaking research, meet the poster presenters and ask your questions.

Showing 4 of 4 Streams
11:20 - 11:50
Use Cases of PAT Integration in CGT Processes and Implementation of Advanced Control Strategies
  • Rolando Matos - Senior Scientist, Cell and Gene Therapy Catapult
11:50 - 12:20
5 Opportunities for AI Integration in Process Development
  • Stefan Bostock - CEO & Co-Founder, Danu Insights
12:20 - 12:50
Navigating the Evolving European Regulatory Landscape for Cell and Gene Therapies
  • Paolo Morgese - VP Public Affairs EMEA, Alliance for Regenerative Medicine
11:20 - 11:50
ROOM EUROPA 6: Use Cases of PAT Integration in CGT Processes and Implementation of Advanced Control Strategies
  • Rolando Matos - Senior Scientist, Cell and Gene Therapy Catapult
11:50 - 12:20
ROOM EUROPA 6: 5 Opportunities for AI Integration in Process Development
  • Stefan Bostock - CEO & Co-Founder, Danu Insights
12:20 - 12:50
ROOM EUROPA 6: Navigating the Evolving European Regulatory Landscape for Cell and Gene Therapies
  • Paolo Morgese - VP Public Affairs EMEA, Alliance for Regenerative Medicine
11:20 - 11:50
EVerGel: Our Current Journey Toward the Clinic
  • Clément Bonamy - Head of R&D Platform, Everzom
11:50 - 12:20
Manufacturing, regulatory compliance, and clinical development of EXO-101
  • Andreia Silva - Head of Research, Exogenus Therapeutics
12:20 - 12:50
Like Parent, Like Vesicle? Can MSC-Derived EVs Surpass Parent Cells' Clinical Roadblocks? First-in-Human Evidence.
  • Maroun Khoury, PhD - CSO, Executive Director, Full Professor, EVast BIO /Cells for Cells / IMPACT center
11:20 - 11:25
Chairperson
  • Christian Reinsch - Vice President Technology Profiling, BioNTech SE
11:25 - 11:55
Enabling LNP-DNA Delivery to Target Peripheral Nerve Diseases
  • Gonzalo Fernández-Miranda - CEO and Co-Founder, CureAge Therapeutics
11:55 - 12:25
Targeted Lipid Nanoparticles Deliver Immune-Silent ssDNA to Generate CAR T Cells
  • Matthias Bozza - Director, Head of Strategy and R&D, CPTx
Showing 1 of 1 Streams
12:50 - 13:55
Networking Lunch in the Exhibition Hall
Showing 4 of 4 Streams
13:55 - 14:00
Chairperson
  • Nicole Lund - Senior Director of Analytical & Quality Control, BlueRock Therapeutics
14:00 - 14:30
Off-The-Shelf Immune-Shielded iPSC-Derived Armored CAR γδ T Cells as a Novel Cell Therapy to Treat Hepatocellular Carcinoma
  • Stephanie Sontag - Senior Research Scientist, Evotec International GmbH
14:30 - 14:50
Cell Therapy Innovation Showcase: Captain T Cell
  • Alberto Sada Japp - Senior Director - R&D, Captain T Cell
14:50 - 15:10
ImmunoKey Ltd -Engineering Tumour Selectivity into Multi-Antigen CAR T-Cell Therapy. CARKey; A Dual-Receptor Platform for Solid Tumours
  • Gray Kueberuwa - Chief Executive Officer, ImmunoKey Ltd
15:10 - 15:30
NeutroGen Therapeutics- Restoring Innate Immunity: Developing Off-the-Shelf Neutrophil Transfusions for Severe Neutropenia
  • Lorenz Knackstedt - Chief Technology Officer, NeutroGen Therapeutics
13:55 - 14:00
Chairperson
  • Marion Hitchcock - Managing Director Gene & Cell Therapies Incubator Berlin and R&D Strategy & Portfolio Manager, Bayer
14:00 - 14:20
Ikarovec - Development Of A Dual-Pathway Gene Therapy for Blindness
  • Andy Osborne - Vice President of Pre-Clinical Research, Ikarovec
14:20 - 14:40
Kindling Bio - Igniting Cancer Gene Therapy: Delivering Impact For Children and Beyond
  • Aleck Jones - CEO, Kindling Bio
14:40 - 15:00
Gene Therapy Innovation Showcase: EpiBlok Therapeutics GmbH
  • Regine Heilbronn - Co-Founder and CEO, EpiBlok Therapeutics
15:00 - 15:20
CREATe Therapeutics: A First-In-Class Drug-Controlled CNS Gene Therapy with PoC in Focal Epilepsy
  • Tamás Kitka - Founder, Managing Director, CREATe Therapeutics
14:00 - 14:30
Development of DB503, an engineered TSG-6 exosome therapeutic for Traumatic Brain Injury
  • Kuldeep Neote - CEO, Diadem Biotherapeutics
14:30 - 15:00
Genetically Programmed Extracellular Vesicles for Cell Targeting and Novel Therapeutic Development
  • Christopher Locher - CEO & Co-Founder, Versatope, USA
15:00 - 15:30
MEVs: A Programmable Oral Platform for Engineered Immunomodulatory Payloads Acting on Innate or Adaptive Immunity
  • Manuel Vega - CEO, AGS Therapeutics
13:55 - 14:00
Chairperson
  • Christian Reinsch - Vice President Technology Profiling, BioNTech SE
14:00 - 14:30
R&D Innovations: Case Studies Next-Generation Therapeutic Applications of LNPs
  • Katia Lemdani - Director Research and Development, Neovacs
14:30 - 15:00
Engineering LNPs for Next Generation Vaccines & Therapeutics
  • Heinrich Haas - Chief Technology Officer, NeoVac
15:00 - 15:30
Refining LNP Design: Formulation Variables Influencing Biological Performance
  • Aadarash Zia - Senior Scientist - Drug Delivery, Medicines Discovery Catapult
Showing 1 of 1 Streams
15:30 - 16:00
Afternoon Coffee and Networking Break in Exhibition Hall
16:00 - 16:05
Close of Event 2026 – See You Next Year!
Wednesday 4th November – Day 1 Main Conference
Filter
Streams
Choose Day